Home Pill Identifier barr 323 25

barr 323 25

Pill imprint barr 323 25 has been identified as Hydroxyzine pamoate 25 mg.

Hydroxyzine is used in the treatment of pain; anxiety; nausea/vomiting; sedation; allergies (and more), and belongs to the drug classes antihistamines, miscellaneous anxiolytics, sedatives and hypnotics. FDA has not classified the drug for risk during pregnancy.

Hydroxyzine 25 mg is not subject to the Controlled Substances Act.
See also related documents.

Hydroxyzine pamoate Images

Imprint:
barr 323
25
Strength:
25 mg
Color:
Pink & White
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
corn starch
lactose anhydrous
D&C Red No. 28
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
titanium dioxide
ferrosoferric oxide
aluminum oxide
FD&C Blue No. 2
propylene glycol
shellac
Drug Class:
Antihistamines
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
N - Not yet classified
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Barr Laboratories, Inc.
National Drug Code (NDC):
00555-0323
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0077 UDL Laboratories Inc
54569-2353 A S Medication Solutions LLC (repackager)
68115-0177 Dispensexpress Inc (repackager)
16590-0357 Stat RX USA LLC (repackager)
23490-5733 Palmetto State Pharmaceuticals Inc (repackager)
67544-0791 Prepak Systems Inc (repackager)
18837-0355 Innoviant Pharmacy Inc (repackager)
49999-0701 Lake Erie Medical and Surgical Supply (repackager)
66267-0114 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Hydroxyzine pamoate 25 mg barr 323 25
Advertisement
Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web4)